Vaccine List

(diphtheria, tetanus acellular, and pertussis adult vaccine - also called Tdap) is used to help prevent tetanus, diphtheria, and pertussis in people who are at least 10 years old. Most people in this age group require only one Tdap shot for protection against these diseases.  Adacel vaccine is...Read more...

In Affinivax’s MAPS vaccine against pneumococcus, proprietary pneumococcal protein antigens enable the potential for an additional immune response to protect against disease due to a broader range of ‘non-vaccine’ pneumococcal serotypes, beyond what is covered by today’s vaccines.

The...Read more...

BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B.

BEXSERO is approved for use in individuals 10 through 25 years of age.

BEXSERO meningitis B vaccine that can be completed in as fast as 1 month with just 2 doses.

The...Read more...

BPZE1 is a live, attenuated form of the pertussis bacterium. BPZE1 is given as a mist into the nose, rather than a shot in the arm. ILiAD Biotechnologies, LLC (ILiAD) is providing the vaccine.

FDA has cleared the Investigational New Drug (IND) application for a Phase 2a BPZE1 study at the...Read more...

Dengvaxia® is approved for use in several endemic countries in Latin America and Asia where reducing the human and economic burden of dengue is critical.

The vaccine is currently under priority review by the US Food and Drug Administration (FDA) as it would be considered a significant...Read more...

ENGERIX-B is a vaccine indicated for immunization against infection caused by all known subtypes of hepatitis B virus. Primary immunization for infants (born of hepatitis B surface antigen [HBsAg]-negative or HBsAg-positive mothers), children (birth through 10 years), and adolescents (aged 11...Read more...

FLUAD is a vaccine that helps protect against the flu. FLUAD is for people aged 65 years and older. Vaccination with FLUAD may not protect all people who receive the vaccine.Read more...

Flublok and Flublok Quadrivalent vaccines are given to people 18 years of age and older to help prevent influenza disease caused by influenza A virus subtypes and influenza type B virus contained in the vaccine. Read more...

Flucelvax Tetra will be the first cell-based quadrivalent influenza vaccine (QIVc) available in Europe. The cell-based technology represents one of the most momentous changes in the way influenza vaccines are manufactured since the 1940s.Read more...

The Advisory Committee on Immunization Practices (ACIP) recommended that FluMist Quadrivalent not be used for the 2016-2017 season. FluMist Quadrivalent is a vaccine that is sprayed into the nose to help protect against influenza. It can be used in children, adolescents, and adults ages 2...Read more...

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone Quadrivalent vaccine is given to people 6 months of age and older. Fluzone...Read more...

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone Intradermal Quadrivalent vaccine is given to people 18...Read more...

GARDASIL is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine: Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16 and 18, Genital warts (condyloma...Read more...

HARVONI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype (GT) 1, 4, 5 or 6 infection with or without cirrhosis (compensated). In those with GT 1 and advanced cirrhosis (decompensated) or with GT 1 or 4 with or without cirrhosis (...Read more...

HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)] is an intravenous immune globulin indicated for the following: Prevention of Hepatitis B recurrence following liver transplant in HBsAg-positive liver transplant patients.  Post-exposure prophylaxis...Read more...

HydroVax-001 experimental vaccine was discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University (OHSU) in Portland.

The scientists were funded with a $7.2 million grant awarded in 2009 from NIAID, part of the National...Read more...

INFANRIX is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age (prior to seventh birthday).Read more...

Ixiaro is indicated for active immunization for the prevention of disease caused by Japanese encephalitis virus (JEV) and is approved for use in individuals 2 months of age and older.

Ixiaro was approved in the US on March 30, 2009, which is also its international birthdate. Currently,...Read more...

FluGen’s M2SR vaccine utilizes a proprietary M2 deleted, single replication (M2SR) influenza virus.

The M2 gene is essential for the influenza virus to spread in the patient and the deletion of the M2 gene restricts the virus to a single replication cycle in the host.

The body...Read more...

Menactra vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menactra vaccine is approved for use in individuals 9 months through 55 years of age. Menactra vaccine does not prevent N meningitidis...Read more...

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age. MENVEO does not prevent N. meningitidis serogroup B infections...Read more...

Vaccitech’s MVA-M1+NP vaccine candidate aims to prevent a pandemic and seasonal influenza by eliciting broader and more durable immune protection against all “A strains” of the virus, which cannot be achieved by traditional vaccination. 

The vaccine consists of MVA, a replication-...Read more...

mRNA-1653 is designed to protect against human metapneumovirus (hMPV) and parainfluenza type 3 (PIV3), two viruses that cause respiratory infections. 

It is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in...Read more...

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.

The vaccine, known as NeoVax, is based on research at Dana-Farber led by Catherine Wu, M.D.  ...Read more...

PAMVAC is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).

PAMVAC was found safe during a ...Read more...

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. PedvaxHIB should not be used in infants <6 weeks of age.Read more...

Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to H influenzae type b. Pentacel vaccine is approved for use as a 4-dose series in children 6 weeks through 4 years of age (prior to the fifth birthday).Read more...

Prevnar 13® is a vaccine indicated in children 6 weeks through 17 years (prior to the 18th birthday) for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, and for children 6 weeks...Read more...

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.

PRV-101 is currently in an IND-...Read more...

RABAVERT is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups.Read more...

RiVax® is Soligenix’s proprietary vaccine developed to protect against exposure to ricin toxin and is the most advanced vaccine product in the company’s portfolio.

With RiVax®, Soligenix is a world leader in ricin toxin vaccine research.

The immunogen in RiVax® induces a protective...Read more...

RotaTeq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by Types G1, G2, G3, G4, and G9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of RotaTeq should be administered between 6 and 12 weeks of age....Read more...

SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster) in adults 50 years and older. SHINGRIX is not used to prevent chickenpox.Read more...

Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B The effectiveness of the two-dose schedule of Trumenba against diverse N meningitidis serogroup B strains has not been confirmed...Read more...

TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. TWINRIX is approved for use in persons 18 years of age or older.Read more...

UB-311, a novel synthetic peptide vaccine targeting beta amyloid (Aβ) in the treatment of Alzheimer's disease.

Currently completed a Phase 2a clinical trial study.  

The top-line Phase 2a data met the...Read more...

VAQTA is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.Read more...

VARIZIG [Varicella Zoster Immune Globulin (Human)] is indicated in the United States for post-exposure prophylaxis of varicella (chickenpox) in high risk patient groups including immunocompromised children, newborns, and pregnant women. VARIZIG is intended to reduce the severity of chickenpox...Read more...

Vivotif is an oral vaccine for typhoid fever, a potentially severe and life-threatening infection caused by the bacterium Salmonella enterica serotype Typhi ( S Typhi). Taken orally, the vaccine is delivered to the mucosal surface of the gastrointestinal tract—the largest immunologic organ in...Read more...

Valneva initiated a Phase 1 clinical trial in the US to evaluate the safety and immunogenicity of VLA1553, its live-attenuated vaccine candidate against...Read more...

YF-VAX is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories: Persons Living in or Traveling to Endemic Areas, Persons Travelling Internationally Through Countries with Yellow Fever, Laboratory PersonnelRead more...